Cited by 1,509Chemotherapy-induced cardiotoxicity and mitigationBioactive Compounds and Antitumor AgentsCancer therapeutics and mechanisms

The DOI matches its Crossref record.

Doxorubicin: The Good, the Bad and the Ugly Effect

Carvalho, Cristina, Santos, Renato, Cardoso, Susana, Correia, Sonia, Oliveira, Paulo, Santos, Maria, Moreira, Paula·2009·Current Medicinal Chemistry

DOI 10.2174/092986709788803312

Open this paper in CoChat — free account

Abstract

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense debate. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients' life during and after DOX treatment. The literature shows that the heart is a preferential target of DOX toxicity. However, this anticancer drug also affects other organs like the brain, kidney and liver. This review is mainly devoted to discuss the mechanisms underlying not only DOX beneficial effects but also its toxic outcomes. Additionally, clinical studies focusing the therapeutic efficacy and side effects of DOX treatment will be discussed. Finally, some potential strategies to attenuate DOX-induced toxicity will be debated.

Integrity signals

Registry

Crossref · 10.2174/092986709788803312

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–600 of 1,000

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
Hu, X., Li, C., Wang, Q., Wei, Z., Chen, T.-Z., Wang, Y., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872057 · Cited by 27
“caesius and is widely used in clinical for multiple malignant tumor treatment (Carvalho et al., 2009; Damiani et al., 2016).”
Background
Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy
Li, Q., Fan, J., Mu, H., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108947 · Cited by 25
Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells
Kwak, J. H., Park, J. Y., Lee, D., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.041 · Cited by 25
The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure
Lindsey, M. L., Lange, R. A., Parsons, H. M., Andrews, T. C., & Aune, G. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00099.2014 · Cited by 25
Synthesis, biological activity and structural study of new benzotriazole-based protein kinase CK2 inhibitors
Świder, R., Masłyk, M., Zapico, J. M., et al. (2015) · RSC Advances · doi:10.1039/c5ra12114k · Cited by 25
Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K/Akt, and mTOR signaling pathways
Mohamed, E. A., Ahmed, H. I., & Zaky, H. S. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0259 · Cited by 26
Pyrroloquinoline quinine ameliorates doxorubicin-induced autophagy-dependent apoptosis via lysosomal-mitochondrial axis in vascular endothelial cells
Jiang, C., Jiang, L., Li, Q., Liu, X., Zhang, T., Yang, G., Zhang, C., Wang, N., Sun, X., & Jiang, L. (2019) · Toxicology · doi:10.1016/j.tox.2019.152238 · Cited by 24
Betaine ameliorates doxorubicin‐induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK /Nrf2/ TGF ‐β expression
Singh, S. K., Yadav, P., Patel, D., Tanwar, S. S., Sherawat, A., Khurana, A., Bhatti, J. S., & Navik, U. (2024) · Environmental Toxicology · doi:10.1002/tox.24291 · Cited by 25
“3 So far, there are two known mechanisms by which DOX exerts an anti-cancer effect: (a) intercalating into DNA strands and disrupting topoisomerase-II to prevent DNA repair, and (b) production of reactive oxygen species (ROS) and other free radicals causing damage to DNA, membrane, and lipid,…”
A novel doxorubicin/CTLA-4 blocker co-loaded drug delivery system improves efficacy and safety in antitumor therapy
Yang, W., Sun, Q., Zhang, X., Zheng, L., Yang, X., He, N., Pang, Y., Wang, X., Lai, Z., Zheng, W.-P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06776-6 · Cited by 28
“Chemotherapy alone is unable to completely and permanently destroy the tumor microenvironment [10].”
Background
Lycopene inhibits doxorubicin-induced heart failure by inhibiting ferroptosis through the Nrf2 signaling pathway
Huang, R. Y., Zhou, C., Wang, T., Chen, Y., Xie, Z., Wei, L., Duan, Y., Liao, C., Ma, C., & Yang, X. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123452 · Cited by 24
Carbon nanoparticles suspension injection for the delivery of doxorubicin: Comparable efficacy and reduced toxicity
Huang, Y., Xie, P., Yang, S., et al. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.012 · Cited by 24
In vitro potentiation of doxorubicin by unseeded controlled non-inertial ultrasound cavitation
Fant, C., Lafond, M., Rogez, B., Castellanos, I. M. S., Ngo, J., Mestas, J., Padilla, F. R., & Lafon, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-51785-7 · Cited by 24
“Three experimental conditions were studied, with 4 samples per condition: (1) DXR at RT of 24 °C (DXR-RT), (2) DXR heated at 29 °C (DXR-29), (3) DXR heated at 37 °C (DXR-37).”
MethodInfluential
Functional Redox Proteomics Reveal That Salvia miltiorrhiza Aqueous Extract Alleviates Adriamycin-Induced Cardiomyopathy via Inhibiting ROS-Dependent Apoptosis
Hung, Y., Wang, P.-W., Lin, T.-Y., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5136934 · Cited by 24
“However, the severe cardiotoxicity of ADR greatly restricts its clinical utilization [1, 2].”
Background
Role of Prohibitins in Aging and Therapeutic Potential Against Age-Related Diseases
Belser, M., & Walker, D. W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.714228 · Cited by 26
Isoginkgetin synergizes with doxorubicin for robust co-delivery to induce autophagic cell death in hepatocellular carcinoma
Wang, Y., Yi, Y., Yao, J., Wan, H., Yu, M., Ge, L., Zeng, X., Wu, M., & Mei, L. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.035 · Cited by 26
Crystalline Nanoparticles of Water‐Soluble Covalent Basket Cages (CBCs) for Encapsulation of Anticancer Drugs
Gunawardana, V. W. L., Ward, C. R., Wang, H., Holbrook, J. H., Sekera, E. R., Cui, H., Hummon, A. B., & Badjić, J. D. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202306722 · Cited by 24
Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells
Lee, S.-J., Hwang, S.-O., Noh, E. J., et al. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.149 · Cited by 24
The minipig as a new model for the evaluation of doxorubicin‐induced chronic toxicity
Manno, R. A., Grassetti, A., Oberto, G., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3266 · Cited by 24
“Being an anthracycline antibiotic, it inhibits DNA replication and RNA synthesis, resulting in reduced cancer cell division and growth (Momparler et al., 1976; Fornari et al., 1994; Carvalho et al., 2009; Du et al., 2010; Goolsby and Lombardo, 2006, Li et al., 2015).”
Background
Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
Andrés, C. M. C., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Pérez‐Lebeña, E. (2024) · Cancers · doi:10.3390/cancers16183123 · Cited by 26
Beneficial Effects of Butyrate on Kidney Disease
Diep, T. N., Liu, H., & Yan, L. (2025) · Nutrients · doi:10.3390/nu17050772 · Cited by 23
“This form of kidney injury is often considered as acute kidney injury [105].”
Antibiotic doxorubicin and its derivative bind milk β-lactoglobulin
Agudelo, D., Beauregard, M., Bérubé, G., et al. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.09.014 · Cited by 23
Therapeutic nanodendrites: current applications and prospects
Oladipo, A. O., Nkambule, T. T. I., Mamba, B. B., et al. (2020) · Nanoscale Advances · doi:10.1039/d0na00672f · Cited by 23
Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy
Tan, R., Tian, D., Liu, J., Wang, C., & Wan, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s314705 · Cited by 23
Tunneling nanotube formation promotes survival against 5‐fluorouracil in MCF‐7 breast cancer cells
Kato, K., Nguyen, K. T., Decker, C. W., Silkwood, K. H., Eck, S. M., Hernandez, J. B., Garcia, J., & Han, D. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13324 · Cited by 23
Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis
Sirwi, A., Shaik, R. A., Alamoudi, A. J., Eid, B. G., Kammoun, A. K., Ibrahim, S. R. M., Mohamed, G. A., Abdallah, H. M., & Abdel‐Naim, A. B. (2021) · Nutrients · doi:10.3390/nu13114142 · Cited by 23
Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer
Wan, Q., Zeng, Z., Qi, J., Chen, Z., Liu, X., & Zu, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.004 · Cited by 22
A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals
Abbasnezhad, A., Salami, F., & Mohebbati, R. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12230 · Cited by 23
Bioinspired Nanocomplexes Comprising Phenolic Acid Derivative and Human Serum Albumin for Cancer Therapy
Wang, Z., Liu, Y., Li, S., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03763 · Cited by 23
Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats
Mani, V., Rabbani, S. I., Shariq, A., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15121563 · Cited by 23
“Administration of DOX is known to cause several adverse effects ranging from mild to severe intensity [8].”
Background
Doxorubicin-loaded polymeric nanoparticles containing ketoester-based block and cholesterol moiety as specific vehicles to fight estrogen-dependent breast cancer
Misiak, P., Niemirowicz-Laskowska, K., Markiewicz, K. H., Wielgat, P., Kurowska, I., Czarnomysy, R., Misztalewska‐Turkowicz, I., Car, H., Bielawski, K., & Wilczewska, A. Z. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00176-9 · Cited by 25
“Doxorubicin (DOX) is the most widely used drug in the treatment of breast cancer (Carvalho et al. 2009; Gonçalves et al. 2020).”
Background
Modifying superparamagnetic iron oxides nanoparticles for doxorubicin delivery carriers: a review
Doan, L., Nguyen, L. T., & Nguyen, N. T. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05716-3 · Cited by 25
Nylon-6-Coated Doxorubicin-Loaded Magnetic Nanoparticles and Nanocapsules for Cancer Treatment
Kovrigina, E., Poletaeva, J., Zheng, Y., et al. (2023) · Magnetochemistry · doi:10.3390/magnetochemistry9040106 · Cited by 23
“Doxorubicin (DOX) is a widely used anthracycline antibiotic applied in many types of cancers [2–6].”
High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage
Gergely, S., Hegedűs, C., Lakatos, P., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/178513 · Cited by 23
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer
Yang, F., Hu, Y., Shao, L., Zhuang, J., Huo, Q., He, S., Chen, S., Wang, J., & Xie, N. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00649-2 · Cited by 23
“The clinical utility of ADR and other anthracyclines is, however, limited by their toxicity [30].”
Background
Tuning the In Vivo Transport of Anticancer Drugs Using Renal‐Clearable Gold Nanoparticles
Peng, C., Xu, J., Yu, M., Ning, X., Huang, Y., Du, B., Hernandez, E., Kapur, P., Hsieh, J., & Zheng, J. (2019) · Angewandte Chemie · doi:10.1002/ange.201903256 · Cited by 24
CARI III Inhibits Tumor Growth in a Melanoma-Bearing Mouse Model through Induction of G0/G1 Cell Cycle Arrest
Park, H.-J. (2014) · Molecules · doi:10.3390/molecules190914383 · Cited by 23
Anticancer Therapies Based on Oxidative Damage: Lycium barbarum Inhibits the Proliferation of MCF-7 Cells by Activating Pyroptosis through Endoplasmic Reticulum Stress
Miranda, M. R., Basilicata, M. G., Vestuto, V., Aquino, G., Marino, P., Salviati, E., Ciaglia, T., Domínguez‐Rodríguez, G., Moltedo, O., Campiglia, P., et al. (2024) · Antioxidants · doi:10.3390/antiox13060708 · Cited by 23
“Doxorubicin is known for its pro-oxidant effects at cardiac and endothelial levels, thereby limiting its therapeutic utility [87].”
Background
Tunable Zn-MOF-74 nanocarriers coated with sodium alginate as versatile drug carriers
Kazemi, A., Afshari, M. H., Baesmat, H., Manteghi, F., Nabipour, H., Rohani, S., & Saeb, M. R. (2024) · Polymer Bulletin · doi:10.1007/s00289-024-05426-3 · Cited by 22
“Despite their effectiveness, anthracyclines have dose-limiting toxicity [33, 34].”
Smart albumin-loaded Rose Bengal and doxorubicin nanoparticles for breast cancer therapy
Sun, J., Zhang, L., Zhang, Y., Yue, C., Lin, J., Wang, H., Fang, Z., & Wu, J. (2019) · Journal of Microencapsulation · doi:10.1080/02652048.2019.1671908 · Cited by 22
“In addition, DOX also has severely adverse effects, such as cardiotoxicity and myelosuppression (Carvalho et al. 2009, Peetla et al. 2010).”
Background
Phototoxic effectiveness of zinc phthalocyanine tetrasulfonic acid on MCF-7 cells with overexpressed P-glycoprotein
Chekwube, A. E., George, B. P. A., & Abrahamse, H. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.111811 · Cited by 22
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
Zhan, C., Bai, N., Zheng, M., Wang, Y., Wang, Y., Zhang, L., Li, J., Li, G., Zhao, H., Liu, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118984 · Cited by 22
Kaempferol attenuates doxorubicin-mediated nephropathy in rats by activating SIRT1 signaling
Alagal, R. I., AlFaris, N. A., Alshammari, G. M., ALTAMIMI, J. Z., ALMOUSA, L. A., & Yahya, M. A. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104918 · Cited by 23
Elabela blunts doxorubicin-induced oxidative stress and ferroptosis in rat aortic adventitial fibroblasts by activating the KLF15/GPX4 signaling
Zhang, M.-W., Li, X., Zhang, Z.-Z., Liu, Y., Song, J.-W., Liu, X., Chen, Y.-H., Wang, N., Guo, Y., Liang, L., et al. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01317-6 · Cited by 22
Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
Passos, J. S., Dartora, V. F. C., Salata, G. C., Malagó, I. D., & Lopes, L. B. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122681 · Cited by 22
The Anti-Cancer Effect of Cinnamon Aqueous Extract: A Focus on Hematological Malignancies
Caserta, S., Genovese, C., Cicero, N., Gangemi, S., & Allegra, A. (2023) · Life · doi:10.3390/life13051176 · Cited by 27
“Doxorubicin is an anthracycline used in the treatment of various kinds of cancers, such as leukemia, and its use is related to adverse effects such as cardio-toxicity and hepatic toxicity [83].”
Background
Synthesis, Characterization, Molecular Docking and in vitro Biological Studies of Thiazolidin‐4‐one Derivatives as Anti‐Breast‐Cancer Agents
Şenol, H., Ağgül, A. G., & Atasoy, S. (2023) · ChemistrySelect · doi:10.1002/slct.202300481 · Cited by 22
DNA as highly biocompatible carriers for drug delivery
Han, G., Лю, Б., Kong, D., & Zhu, L. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00395g · Cited by 23
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Ibrahim, A. A., Nsairat, H., Al-Sulaibi, M., El‐Tanani, M., Jaber, A. M., Lafi, Z. M., Barakat, R., Abuarqoub, D. A., Mahmoud, I. S., Obare, S. O., et al. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2343882 · Cited by 25
pH-Sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriers
Luong, A. K., Issarapanichkit, T., Kong, S. D., et al. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00228c · Cited by 22
Developing a rat model of dilated cardiomyopathy with improved survival
Shen, L., Lu, S. T., Zhou, Y., et al. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600257 · Cited by 22
“YGZX1102), China # Electronic supplementary materials: The online version of this article (http://dx.doi.org/10.1631/jzus.B1600257) contains supplementary materials, which are available to authorized users ORCID: Li-juan SHEN, http://orcid.org/0000-0001-6401-3220 © Zhejiang University and…”
Influential
Effects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in mice.
Yang, Y., Zhang, H., Li, X., Yang, T., & Jiang, Q. (2014) · PubMed Central · Cited by 22
Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression
Guo, L., Zheng, P., Fan, H., Wang, H., Xu, W., & Zhou, W. (2017) · Bioscience Reports · doi:10.1042/bsr20171137 · Cited by 22
Mesenchymal stem cells attenuate doxorubicin‑induced cellular senescence through the VEGF/Notch/TGF‑β signaling pathway in H9c2 cardiomyocytes
Chen, L., Xia, W., & Hou, M. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3635 · Cited by 22
“Despite its effectiveness against cancer, its dose‐dependent cardiotoxicity restricts its long‐term use in chemotherapy as it reduces the quality of life of patients with cancer (2).”
Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
Gao, L., Li, Q., Zhang, J., Huang, Y., Deng, L., Li, C., Tai, G., & Ruan, B. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1676842 · Cited by 23
“Doxorubicin (DOX) is widely used in the chemotherapy of a wide range of cancers, including breast, bileducts, prostate, uterus, ovary, esophagus, stomach and liver tumors, childhood solid tumors, osteosarcomas and soft tissue sarcomas, Kaposi’s sarcoma, acute myeloblastic leukemia, lymphoblastic leukemia and Wilms tum…”
Background
Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
Gauthier, F., Bertrand, J., Vasseur, J., et al. (2020) · Molecules · doi:10.3390/molecules25112714 · Cited by 22
FOXA2 inhibits doxorubicin-induced apoptosis via transcriptionally activating HBP rate-limiting enzyme GFPT1 in HCC cells
Huang, H., Wang, Y., Huang, T., Wang, L., Liu, Y., Wu, Q., Yu, A., Shi, M., Wang, X., Li, W., et al. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00829-6 · Cited by 23
“Consistent with the Annexin V-FITC-PI staining results, FOXA2 knockdown–mediated elevation of caspase-3 activity and intracellular ROS were eliminated by GFPT1 overexpression after 0.5 µM DOX treatment for 6 h in HepG2 cells, while FOXA2 overexpression–induced reduction of caspase-3 activity and intracellular ROS were…”
BackgroundInfluential
Experimental animal models of drug-induced sensorineural hearing loss: a narrative review
Lin, X., Luo, J., Tan, J., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2508 · Cited by 22
“DOXO is a common antitumor medication that intercalates into the DNA strand to interfere with DNA-directed mRNA synthesis (82).”
Background
Bio‐based Nanomaterials and Their Bionanocomposites
Bagal-Kestwal, D., Kestwal, R. M., & Chiang, B. (2016) · Wiley eBooks · doi:10.1002/9783527683772.ch8 · Cited by 28
Doxorubicin-loaded pH-responsive porphyrin-derived carbon dots as a promising biocompatible drug delivery system for effective chemotherapy of breast cancer
Ansary, A., Osman, A., & El-Khouly, M. E. (2025) · RSC Advances · doi:10.1039/d4ra09058f · Cited by 11
Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game
Arruda, F. D. S., Tomé, F. D., Miguel, M. P., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190312110836 · Cited by 21
Thermodynamic Theory of Multiresponsive Microgel Swelling
Pérez-Chávez, N. A., Albesa, A. G., & Longo, G. S. (2021) · Macromolecules · doi:10.1021/acs.macromol.0c02885 · Cited by 21
Application Perspectives of Nanomedicine in Cancer Treatment
Hou, S., Hasnat, M., Chen, Z., Liu, Y., Baig, M. M. F. A., Liu, F., & Chen, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909526 · Cited by 23
“Doxorubicin, used alone or in combination with other drugs, is one of the most effective chemotherapeutic drugs commonly used clinically, which can treat a variety of tumors including solid tumors and hematological tumors by inhibiting DNA synthesis (Carvalho et al., 2009).”
Background
Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma
Guo, S., Bai, X., Shi, S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113392 · Cited by 21
Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats
Dantas, D., Pereira, A. G., Fujimori, A. S. S., Ribeiro, A. P. D., Silva, C. C. V. D. A., Monte, M. G., Corrêa, C. R., Fernandes, A. A. H., Bazan, S. G. Z., Azevedo, P. S., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080254 · Cited by 21
Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity
Kawalec, P., Martens, M. D., Field, J. T., Mughal, W., Caymo, A. M., Chapman, D. C., Xiang, B., Ghavami, S., Dolinsky, V. W., & Gordon, J. W. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116210 · Cited by 21
Effects of melatonin on cardiac metabolic reprogramming in doxorubicin‐induced heart failure rats: A metabolomics study for potential therapeutic targets
Thonusin, C., Nawara, W., Arinno, A., Khuanjing, T., Prathumsup, N., Ongnok, B., Chattipakorn, S. C., & Chattipakorn, N. (2023) · Journal of Pineal Research · doi:10.1111/jpi.12884 · Cited by 24
“Unfortunately the clinical utilization of doxorubicin is sometimes limited owing to its serious adverse effects on the noncancerous tissues.(3) Among these, cardiotoxicity is considered as a major, and the most lethal, side effect of doxorubicin.”
Background
Acoustofluidic control of chemical concentration within picoliter droplets in a disposable microfluidic chip
Kim, W., Cha, B., Jeon, J. S., & Park, J. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134132 · Cited by 21
Exploring the effective components of honey-processed licorice (Glycyrrhiza uralensis Fisch.) in attenuating Doxorubicin-induced myocardial cytotoxicity by combining network pharmacology and in vitro experiments
Sun, P., Chen, H., Chen, H., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118178 · Cited by 21
Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-β1 signaling pathway in Sprague Dawley rats
Ayyappan, J. P., & Abraham, A. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.09.010 · Cited by 21
A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells
Shi, R., Li, W., Zhang, X., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.047 · Cited by 21
Fitness Profiling Links Topoisomerase II Regulation of Centromeric Integrity to Doxorubicin Resistance in Fission Yeast
Nguyen, T. T. T., Lim, J. S. L., Tang, R. M. Y., Zhang, L., & Chen, E. S. (2015) · Scientific Reports · doi:10.1038/srep08400 · Cited by 21
Fullerenol/doxorubicin nanocomposite mitigates acute oxidative stress and modulates apoptosis in myocardial tissue
Seke, M., Petrović, D., Djordjevic, A. N., Jović, D., Labudović‐Borović, M., Kanački, Z., & Jankovic, M. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/48/485101 · Cited by 21
Biodegradable Polymersomes as Nanocarriers for Doxorubicin Hydrochloride: Enhanced Cytotoxicity in MCF-7/ADR Cells and Prolonged Blood Circulation
Chao, Y., Liang, Y., Fang, G., et al. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2088-9 · Cited by 21
Design of functionalized folic acid–chitosan nanoparticles for delivery of tetracycline, doxorubicin, and tamoxifen
Chanphai, P., Thomas, T., & Tajmir‐Riahi, H. A. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1445559 · Cited by 21
“Doxorubicin is a major antitumor drug used in chemotherapy due to its efficacy in fighting a wide range of cancers (Carvalho et al., 2009; Ma & Mumper, 2013).”
Background
Improving the Efficacy of Anticancer Drugs via Encapsulation and Acoustic Release
Ahmed, S. E., Awad, N. S., Paul, V., Moussa, H. G., & Husseini, G. A. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180608125344 · Cited by 21
“, alkyl lysophospholipid perifosine, edelfosine) instead of using one drug, or by seeking to prolong DOX infusion schedules so as to encourage the growth of healthy cells between chemotherapeutic sessions [43, 45, 52, 55, 174].”
BackgroundInfluential
A size-tunable and multi-responsive nanoplatform for deep tumor penetration and targeted combinatorial radio-/chemotherapy
Dahmani, F. Z., Zhong, D., Qi, Y., Dahmani, A. E. G., Xie, T., Zhou, B., Li, W., Yao, K., Li, L., & Zhou, M. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00716d · Cited by 21
Doxorubicin–Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake
Chaiwaree, S., Prapan, A., Suwannasom, N., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030224 · Cited by 21
“However, DOX is also known to be cardiotoxic [4] and its clinical application is limited by detrimental effect on normal tissues including brain, kidney, liver [5,6] and skin [7].”
Background
Preparation of a size selective nanocomposite through temperature assisted co-assembly of gelatin and pluronic F127 for passive targeting of doxorubicin
Das, R. P., Singh, B. G., & Kunwar, A. (2020) · Biomaterials Science · doi:10.1039/d0bm00725k · Cited by 21
Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
Qu, Y., XIA, P., Zhang, S., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3698 · Cited by 21
“In fact, doxorubicin is the most widely used anticancer drug with FDA approval (37).”
Retracted
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy
Hofmann, G., Balić, M., Dandachi, N., et al. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.06.010 · Cited by 21
Nephroprotective effects of diminazene on doxorubicin-induced acute kidney injury in rats
Suleimani, Y. M. A., Maskari, R. A., Ali, B. H., et al. (2023) · Toxicology Reports · doi:10.1016/j.toxrep.2023.11.005 · Cited by 20
“Exposure to DOX increases superoxide levels, induces lipid peroxidation and reduces natural antioxidant compounds and free radical scavengers [2,3].”
Background
Revolutionizing cancer therapy using tetrahedral DNA nanostructures as intelligent drug delivery systems
Sharma, A., Vaswani, P., & Bhatia, D. D. (2024) · Nanoscale Advances · doi:10.1039/d4na00145a · Cited by 23
“59 To tackle this issue, researchers have investigated drug delivery methods that use TDNs as carriers for DOX.”
Background
Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity
Villegas, C., Cortez, N., Ogundele, A. V., Burgos, V., Pardi, P. C., Cabrera‐Pardo, J. R., & Paz, C. (2024) · Biomolecules · doi:10.3390/biom14070867 · Cited by 22
“However, it also affects other organs such as the brain, kidneys, and liver [80].”
Background
MST1: A future novel target for cardiac diseases
Shao, Y., Wang, Y., Sun, L., Zhou, S., Xu, J., & Xing, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124296 · Cited by 21
Fucoidan based polymeric nanoparticles encapsulating epirubicin: A novel and effective chemotherapeutic formulation against colorectal cancer
Khan, S. H., Anees, M., Zofair, S. F. F., Rasool, F., Khan, M. A., Moin, S., & Younus, H. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124622 · Cited by 21
Fullerene Derivatives for Tumor Treatment: Mechanisms and Application
Hou, W., Shen, L., Zhu, Y., Wang, X., Du, T., Yang, F., & Zhu, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s476601 · Cited by 23
The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals
Dirks‐Naylor, A. J., Tran, N. T. K., Yang, S., et al. (2013) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-013-0104-z · Cited by 20
“As a positive control, we assessed changes in lysine acetylation status in the heart and liver; tissues that are well described to be adversely affected by acute doxorubicin treatment [1].”
Background
“Two‐Step” Raman Imaging Technique To Guide Chemo‐Photothermal Cancer Therapy
Deng, L., Li, Q., Yang, Y., et al. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502522 · Cited by 20
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro
Brisdelli, F., Perilli, M., Sellitri, D., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.023 · Cited by 20
Intelligent anticancer drug delivery performances of two poly(N-isopropylacrylamide)-based magnetite nanohydrogels
Poorgholy, N., Massoumi, B., Ghorbani, M., et al. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1442845 · Cited by 20
Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy
Qiu, Y., Yu, Q., Liu, Y., Tang, J., Wang, X., Lu, Z., Xu, Z., & He, Q. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2399-0 · Cited by 20
Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway
Chen, J., Huang, C., Lee, I., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22899 · Cited by 20
Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy
Ye, P.-J., Huang, C., Yang, S., Gao, P., Li, Z., Tang, S.-Y., Xiang, Y., Liu, Y., Chen, Y., He, D., et al. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1505745 · Cited by 20
The Adjuvant Effect of Squalene, an Active Ingredient of Functional Foods, on Doxorubicin-Treated Allograft Mice
Bhilwade, H. N., Tatewaki, N., Konishi, T., Nishida, M., Eitsuka, T., Yasui, H., Inanami, O., Handa, O., Naito, Y., Ikekawa, N., et al. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1597900 · Cited by 22
“relevant animal models or clinical trials (5).”
Synergistic effect of Zataria Multiflora essential oil on doxorubicin-induced growth inhibition of PC3 cancer cells and apoptosis
Zare, E., Jamali, T., Ardestani, S. K., & Kavoosi, G. (2020) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101286 · Cited by 21
KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma
Gulay, K. C. M., Aoshima, K., Shibata, Y., Yasui, H., Yan, Q., Kobayashi, A., & Kimura, T. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.02.005 · Cited by 20
The dynamic behavior of Ect2 in response to DNA damage
He, D. N., Xiang, J., Li, B., & Liu, H. (2016) · Scientific Reports · doi:10.1038/srep24504 · Cited by 20
Lipoplex-Mediated Deintercalation of Doxorubicin from Calf Thymus DNA–Doxorubicin Complex
Das, A., Adhikari, C., & Chakraborty, A. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b01860 · Cited by 20
Host-guest interaction of ZnBDC-MOF + doxorubicin: A theoretical and experimental study
Alves, I. B. V., Wanderley, K. A., Rodrigues, N. M., Júnior, N. B. D. C., Freire, R. O., & Alves, S. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.11.034 · Cited by 21
Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
Liao, Y., Sassi, S. O., Halvorsen, S. C., et al. (2017) · Scientific Reports · doi:10.1038/srep43941 · Cited by 20

Authors: Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P.
Affiliations: Centro de Neurociências e Biologia Celular (PT)
Corresponding author: Moreira, Paula
ORCID: Carvalho, Cristina
Santos, Renato
Cardoso, Susana
Oliveira, Paulo
Santos, Maria
Moreira, Paula
Venue: Current Medicinal Chemistry
Publisher: Bentham Science Publishers Ltd.
Published: 2009-09-01
Volume: 16
Issue: 25
Pages: 3267-3285
ISSN: 0929-8673 (ISSN-L)
DOI: 10.2174/092986709788803312
OpenAlex: W2102897174
Cited by: 1,509
References: 0
Citations by year: 2026: 102 · 2025: 147 · 2024: 174 · 2023: 169 · 2022: 153 · 2021: 150 · 2020: 120 · 2019: 85 · 2018: 84 · 2017: 53 · 2016: 63 · 2015: 62 · 2014: 43 · 2013: 35 · 2012: 29
FWCI: 14.12
Type: journal article
Language: en
Open access: closed
Locations: Current Medicinal Chemistry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords: doxorubicin, anthracyclines, cardiotoxicity, drug toxicity mechanisms, anticancer mechanism, neurotoxicity, nephrotoxicity, hepatotoxicity, chemotherapy side effects
MeSH terms: Antibiotics, Antineoplastic, Doxorubicin, Humans, Molecular Conformation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Doxorubicin: The Good, the Bad and the Ugly Effect

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks